Elevance Health Inc Ranks High Among Investment Strategies

Elevance Health Inc (ELV) earns a strong rating of 79% per a guru strategy focusing on persistent growth. The positive outlook suggests potential impacts on stock prices given the robust metrics provided.

Date: 14-02-2025

AI Rating: 7

**Earnings Per Share (EPS) Growth:**
Elevance Health Inc (ELV) has successfully passed the EPS growth criteria, indicating that the company has demonstrated consistent earnings growth. This is a positive aspect for potential investors, as sustained earnings can lead to higher stock prices due to increased investor confidence.

**Future EPS Growth:**
The report states that Future EPS Growth also passes, suggesting that analysts expect the company to continue this growth trend. This forecast can further drive the stock price upwards as investors anticipate future profitability.

**Sales Growth:**
ELV has passed the sales growth test as well, highlighting a robust sales performance. This can positively affect stock prices since growing sales typically correlate with increased earnings, leading to better financial health of the company.

**Free Cash Flow (FCF):**
Free cash flow has passed as well, which is a significant indicator of the firm's ability to generate cash after accounting for capital expenditures. A healthy free cash flow can enable the company to invest in growth options, pay dividends, or reduce debt, all of which can enhance stock value.

**Profit Margins:**
No specific profit margin metrics such as gross, operating, or net margins were reported, so these cannot be analyzed here.

**Return on Equity (ROE):**
No information on return on equity was given in the report, which limits the assessment of how effectively the company is utilizing its equity.

**Overall Assessment:**
Overall, the metrics indicating strong EPS growth, future growth, sales growth, and free cash flow present an optimistic picture for Elevance Health Inc. These factors are likely to attract investors and could lead to a positive adjustment in stock price, although the failed criteria related to total return/PE and EPS persistence indicate potential risks that investors should also consider.

Stocks: ELV